BioClin Therapeutics, Inc. (BioClin)

Oncology Corporate Profile

HQ Location

130 Market Place, PMB 295
San Ramon, CA 94583

Company Description

BioClin Therapeutics, Inc. is a privately-held company developing biologics to address medical conditions where there are no approved or effective therapies. The company's lead candidate is B-701, a human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3).


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
B-701FGFR3 monoclonal antibodyBladder cancerII

View additional information on product candidates here »


Recent News Headlines

There are no news items to display